Tenenbaum, Elena J. http://orcid.org/0000-0002-0973-142X
Major, Samantha
Carpenter, Kimberly L. H.
Howard, Jill
Murias, Michael
Dawson, Geraldine
Funding for this research was provided by:
National Institute of Child Health and Human Development (P50HD093074)
Marcus Foundation
Brain and Behavior Research Foundation (23807)
Article History
Accepted: 21 November 2020
First Online: 2 January 2021
Compliance with Ethical Standards
:
: Dr. Dawson is on the Scientific Advisory Boards of Janssen Research and Development, Akili, Inc, LabCorp, Inc, Roche Pharmaceutical Company, and Tris Pharma, and is a consultant to Apple, Gerson Lehrman Group, Guidepoint, Inc, Axial Ventures, Teva Pharmaceutical, and is CEO of DASIO, LLC. Dr. Dawson has received book royalties from Guilford Press, Oxford University Press, Springer Nature Press. In addition, Dr. Dawson has the following patent applications: 1802952, 1802942, 15141391, and 16493754. Dawson and Carpenter helped develop technology for early screening for ASD. The technology has been licensed and Dawson, Carpenter, and Duke University have benefited financially. Dr. Howard reports personal fees from Roche.